iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

iBio (IBIO) posted Return on Capital Employed [ROCE] of -43.53% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 80.17 percentage points from -123.70% a year earlier but down 1.32 percentage points from the prior quarter.

Analysis

iBio (IBIO) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), iBio's Return on Capital Employed [ROCE] came in at -71.13%, up 22.56 percentage points from FY2025.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -43.83 percentage points (FY2021 to FY2026).
  • In prior fiscal years, iBio's Return on Capital Employed [ROCE] was -93.70% in FY2025 (-40.26 pp), -53.43% in FY2024 (+7.45 pp), -60.88% in FY2023 (-28.86 pp) and -32.02% in FY2022 (-4.71 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -145.02% in fiscal Q2 2024 to a high of -21.43% in fiscal Q1 2022 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of +29.89 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was fiscal Q4 2024, with a gain of 95.12 percentage points; the weakest was fiscal Q3 2023, with a drop of 109.45 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was -42.21% (Q3 2026), -43.64% (Q2 2026) and -54.35% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 iBio 118.23 Mn -174.02 Mn - -43.99%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -43.99%
Jun 30, 2026 -43.53%
Mar 31, 2026 -42.21%
Dec 31, 2025 -43.64%
Sep 30, 2025 -54.35%
Jun 30, 2025 -123.70%
Mar 31, 2025 -112.06%
Dec 31, 2024 -84.57%
Sep 30, 2024 -67.53%
Jun 30, 2024 -46.72%
Mar 31, 2024 -88.04%
Dec 31, 2023 -145.02%
Sep 30, 2023 -143.10%
Jun 30, 2023 -141.84%
Mar 31, 2023 -134.91%
Dec 31, 2022 -87.73%
Sep 30, 2022 -53.70%
Jun 30, 2022 -38.59%
Mar 31, 2022 -25.47%
Dec 31, 2021 -22.96%
API Access

iBio Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEY